Welcome to LookChem.com Sign In|Join Free

CAS

  • or
**1,4,6-Heptatrien-3-one, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,4Z,6E)-** (also known as a curcuminoid) is a diarylheptanoid compound structurally characterized by a central heptatrienone backbone with hydroxyl and methoxy-substituted phenyl groups at the 1- and 7-positions. It exhibits biological relevance as a curcumin analogue, with studies highlighting its potential as an inhibitor of thioredoxin reductase (TrxR), an enzyme implicated in cancer progression. The presence of the 4-hydroxy-3-methoxyphenyl (vanillyl) groups contributes to its activity, though structural modifications, such as the introduction of a furan moiety, may enhance inhibitory effects. Additionally, its synthesis and derivatization are of interest in mechanochemical approaches for generating fluorinated heterocycles with sensing applications.

147556-16-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one

    Cas No: 147556-16-9

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 147556-16-9 Structure
  • Basic information

    1. Product Name: 1,4,6-Heptatrien-3-one, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,4Z,6E)-
    2. Synonyms:
    3. CAS NO:147556-16-9
    4. Molecular Formula: C21H20O6
    5. Molecular Weight: 368.386
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 147556-16-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1,4,6-Heptatrien-3-one, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,4Z,6E)-(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1,4,6-Heptatrien-3-one, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,4Z,6E)-(147556-16-9)
    11. EPA Substance Registry System: 1,4,6-Heptatrien-3-one, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,4Z,6E)-(147556-16-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 147556-16-9(Hazardous Substances Data)

147556-16-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 147556-16-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,5,5 and 6 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 147556-16:
(8*1)+(7*4)+(6*7)+(5*5)+(4*5)+(3*6)+(2*1)+(1*6)=149
149 % 10 = 9
So 147556-16-9 is a valid CAS Registry Number.

147556-16-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name diferuloylmethane

1.2 Other means of identification

Product number -
Other names curcumin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:147556-16-9 SDS

147556-16-9Relevant articles and documents

Mechanochemical synthesis of 2,2-difluoro-4, 6-bis(β-styryl)-1,3,2-dioxaborines and their use in cyanide ion sensing

Sherin, Daisy R.,Thomas, Sherin G.,Rajasekharan, Kallikat N.

, p. 381 - 385 (2015)

The conversion of arylaldehydes to 1,7-diaryl-5-hydroxyhepta-1,4,6-trien-3-ones (curcuminoids) and the mechanochemical cyclization of these products to 2,2-difluoro-4,6-bis(β-styryl)-1,3,2-dioxaborines using BF3-Et2O are described. Investigation of the cyanide ion sensing ability of the 2,2-difluoro-4,6-bis(β-styryl)-1,3,2-dioxaborines, in relation to the substituent groups on the aryl ring, showed that a hydroxy susbstituent is required, preferably para to the intervening carbon bridge.

Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors

Qiu, Xu,Liu, Zhong,Shao, Wei-Yan,Liu, Xing,Jing, Da-Ping,Yu, Yan-Jun,An, Lin-Kun,Huang, Shi-Liang,Bu, Xian-Zhang,Huang, Zhi-Shu,Gu, Lian-Quan

, p. 8035 - 8041 (2008)

Series of curcumin derivatives were synthesized; the inhibitory activities on thioredoxin reductase (TrxR) of all analogues were evaluated by DTNB assay in vitro. It is found that most of the analogues can inhibit TrxR in the low micromolar range; Structure-activity relationship analysis reveals that analogues with furan moiety have excellent inhibitory effect on TrxR in an irreversible manner, indicating that the furan moiety may serve as a possible pharmacophore during the interaction of curcumin analogues with TrxR. The effect of selected curcuminoids on growth of different TrxR overexpressed cancer cell lines was also investigated and discussed.

Synthesis, anticancer activity, and preliminary pharmacokinetic evaluation of 4,4-disubstituted curcuminoid 2,2-bis(hydroxymethyl)propionate derivatives

Lee, Der-Yen,Hou, Yu-Chi,Yang, Jai-Sing,Lin, Hui-Yi,Chang, Tsu-Yuan,Lee, Kuo-Hsiung,Kuo, Sheng-Chu,Hsieh, Min-Tsang

supporting information, (2020/02/11)

Compound 1 is a curcumin di-O-2,2-bis(hydroxymethyl)propionate that shows significant in vitro and in vivo inhibitory activity against MDA-MB-231 cells with eight to ten-fold higher potency than curcumin. Here, we modified the α-position (C-4 position) of the central 1,3-diketone moiety of 1 with polar or nonpolar functional groups to afford a series of 4,4-disubstituted curcuminoid 2,2-bis(hydroxymethyl)propionate derivatives and evaluated their anticancer activities. A clear structure–activity relationship of compound 1 derivatives focusing on the functional groups at the C-4 position was established based on their anti-proliferative effects against the MDA-MB-231 and HCT-116 cell lines. Compounds 2–6 are 4,4-dimethylated, 4,4-diethylated, 4,4-dibenzylated, 4,4-dipropargylated and 4,4-diallylated compound 1, respectively. Compounds 2m–6m, the ester hydrolysis products of compounds 2–6, respectively, were synthesized and assessed for anticancer activity. Among all compound 1 derivatives, compound 2 emerged as a potential chemotherapeutic agent for colon cancer due to the promising in vivo anti-proliferative activities of 2 (IC50 = 3.10 ± 0.29 μM) and its ester hydrolysis product 2m (IC50 = 2.17 ± 0.16 μM) against HCT-116. The preliminary pharmacokinetic evaluation of 2 implied that 2 and 2m are main contributors to the in vivo efficacy. Compound 2 was further evaluated in an animal study using HCT-116 colon tumor xenograft bearing nude mice. The results revealed a dose-dependent efficacy that led to tumor volume reductions of 27%, 45%, and 60% at 50, 100, and 150 mg/kg doses, respectively. The established structure–activity relationship and pharmacokinetic outcomes of 2 is the guidance for future development of 4,4-disubstituted curcuminoid 2,2-bis(hydroxymethyl)- propionate derivatives as anticancer drug candidates.

DNA-binding and in vitro cytotoxic activity of platinum(II) complexes of curcumin and caffeine

Censi, Valentina,Caballero, Ana B.,Pérez-Hernández, Marta,Soto-Cerrato, Vanessa,Korrodi-Gregório, Luís,Pérez-Tomás, Ricardo,Dell'Anna, Maria Michela,Mastrorilli, Piero,Gamez, Patrick

, (2019/06/18)

Three Pt(II) complexes containing the natural ligands curcumin and caffeine, namely [Pt(curc)(PPh3)2]Cl (1), [PtCl(curc)(DMSO)] (2) (curc = deprotonated curcumin) and trans-[Pt(caffeine)Cl2(DMSO)] (3), were synthesized and

Mining Plants for Bacterial Quorum Sensing Modulators

David, Shimrit,Mandabi, Aviad,Uzi, Shaked,Aharoni, Asaph,Meijler, Michael M.

, p. 247 - 252 (2018/02/06)

The bacterial plant pathogen Agrobacterium tumefaciens uses quorum sensing (QS) in order to regulate the transfer of DNA into the host plant genome, and this results in the induction of crown gall tumors. The deleterious results of these infections are wi

A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin

Muangnoi, Chawanphat,Jithavech, Ponsiree,Na Bhuket, Pahweenvaj Ratnatilaka,Supasena, Wiwat,Wichitnithad, Wisut,Towiwat, Pasarapa,Niwattisaiwong, Nuansri,Haworth, Ian S.,Rojsitthisak, Pornchai

, p. 1301 - 1308 (2018/07/29)

In this work, a curcumin-diglutaric acid (CurDG) prodrug was synthesized by conjugation of curcumin with glutaric acid via an ester linkage. The water solubility, partition coefficient, release characteristics, and antinociceptive activity of CurDG were compared to those of curcumin. The aqueous solubility of CurDG (7.48 μg/mL) is significantly greater than that of curcumin (0.068 μg/mL). A study in human plasma showed that the CurDG completely releases curcumin within 2 h, suggesting the ability of CurDG to serve as a prodrug of curcumin. A hot plate test in mice showed the highest antinociceptive effect dose of curcumin at 200 mg/kg p.o., whereas CurDG showed the same effect at an effective dose of 100 mg/kg p.o., indicating that CurDG significantly enhanced the antinociceptive effect compared to curcumin. The enhanced antinociceptive effect of CurDG may be due to improved water solubility and increased oral bioavailability compared to curcumin.

Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models

Wang, Rubing,Zhang, Xiaojie,Chen, Chengsheng,Chen, Guanglin,Sarabia, Cristian,Zhang, Qiang,Zheng, Shilong,Wang, Guangdi,Chen, Qiao-Hong

, p. 208 - 226 (2017/04/07)

To systematically investigate the structure-activity relationships of 1,7-diheteroarylhepta-1,4,6-trien-3-ones in three human prostate cancer cell models and one human prostate non-neoplastic epithelial cell model, thirty five 1,7-diarylhepta-1,4,6-trien-

Method for artificially synthesizing curcumin and derivative thereof

-

Paragraph 0023; 0024; 0025; 0026, (2017/08/29)

The invention discloses a method for artificially synthesizing curcumin and a derivative thereof. The method comprises the steps of adopting calcium acetylacetonate as a acetylacetone supply source, carrying out claisen-schmidt ester condensation reaction on the calcium acetylacetonate and a corresponding benzaldehyde derivative, and dehydrating under the catalysis of a dehydrating agent which is tributyl borate to obtain a product intermediate (I) which is curcumin calcium salt; then hydrolyzing the intermediate (I) through a one-pot method to obtain a crude product, and purifying the crude product so as to obtain the final product curcumin and the derivative thereof. Compared with a acetylacetone boric acid complex method, according to the method provided by the invention, the calcium acetylacetonate is used, so that active sites of acetylacetonate during a reaction process are more accurate and activated, the generation of by-products is reduced, and the yield of the curcumin and the derivative thereof is improved.

Synthesis of Unnatural 2-Substituted Quinolones and 1,3-Diketones by a Member of Type III Polyketide Synthases from Huperzia serrata

Wang, Juan,Wang, Xiao-Hui,Liu, Xiao,Li, Jun,Shi, Xiao-Ping,Song, Yue-Lin,Zeng, Ke-Wu,Zhang, Le,Tu, Peng-Fei,Shi, She-Po

supporting information, p. 3550 - 3553 (2016/08/16)

A curcuminoids, benzalacetone-, and quinolone-producing type III polyketide synthase (HsPKS3) from Huperzia serrata uniquely catalyzes the formation of unnatural 2-substituted quinolones and 1,3-diketones via head-to-head condensation of two completely different substrates. The broad range of substrate tolerance of HsPKS3 facilitates accessing structurally diverse 2-substituted quinolones and 1,3-diketones.

Novel Dialkyl Curcumin Derivatives and Uses Thereof

-

Paragraph 0056; 0062; 0063, (2017/04/19)

The present invention provides novel dialkyl curcumin derivatives. The dialkyl curcumin derivatives according to the present invention have significant effects in vascularization and tumor growth when compared to curcumin. The dialkyl curcumin derivatives according to the present invention may be used for preventing and curing various vascularization-related diseases and tumor diseases. The dialkyl curcumin derivatives are expressed by chemical formula 1. In the chemical formula 1, R_1 to R_4 are each independently H or C_1-C_5 alkyl; R_5 and R_6 are each independently OH, C_1-C_5 haloalkoxy, polyethyleneoxy, halopolyethyleneoxy, amino, monoalkylamino, dialkylamino, piperidine, piperazine, morpholin, pyrrole, imidazole, benzimidazole, or indole; and R_7 and R_8 are each independently H, OH, or C_1-C_5 alkoxy, wherein the polyethyleneoxy is (ethoxy)_n-OH and n is an integer of 1 to 5.COPYRIGHT KIPO 2016

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 147556-16-9